Finance

Lists
Why is KOAN up 43.33%?
Dive Deeper
KOAN:OTCMKTS
Apollo Biowellness Inc
$0.00043
+43.33%
(+0.00013) 1D
Oct 16, 4:00:00ā€ÆPM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KOAN...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
57.25K
Avg. vol.
2.60M
Volume
25.97M
52-wk high
$0.02
52-wk low
$0.00
Beta
0.01
Shares outstanding
195.25M
No. of employees
6
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
57.25K
Avg. vol.
2.60M
Volume
25.97M
52-wk high
$0.02
52-wk low
$0.00
Beta
0.01
Shares outstanding
195.25M
No. of employees
6
News stories
From web sources and news partners
About Apollo Biowellness Inc
CEO-
Employees6
Founded2010
HeadquartersCalabasas, California, United States
SectorPharmaceutical industry
Websiteapollobiowellness.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2024
Dec 2024
Mar 2025
Revenue
598.63K
546.31K
430.77K
Cost of goods sold
179.16K
182.94K
140.72K
Cost of revenue
179.16K
182.94K
140.72K
Research and development expenses
3.51K
-
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
685.72K
714.03K
620.28K
Operating expense
689.23K
714.03K
620.28K
Total operating expenses
868.38K
896.97K
761.01K
Operating income
-269.76K
-350.66K
-330.24K
Other non operating income
-
3.37K
215.00
EBT including unusual items
-305.50K
-577.44K
-411.82K
EBT excluding unusual items
-273.04K
-577.44K
-411.82K
Income tax expense
-
-
-
Effective tax rate
-
-
-
Other operating expenses
-
-
-
Net income
-305.50K
-577.44K
-411.82K
Net profit margin
-51.03%
-105.70%
-95.60%
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-3.28K
-230.15K
-81.79K
Net interest expenses
-3.28K
-230.15K
-81.79K
Depreciation and amortization charges
-
-
-
EBITDA
-269.76K
-350.66K
-325.96K
Gain or loss from assets sale
69.24K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps